Qiagen NVNYSE:QGEN
- LAST PRICE40.5800
- TODAY'S CHANGE (%)-0.1200 (-0.2948%)
- Bid / Lots0.0000/ 0
- Ask / Lots55.0000/ 1
- Open / Previous Close40.6800 / 40.7000
- Day Range
- 52 Week Range
- Volume291,792
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QGEN |
|---|---|---|
| 09:32 ET | 7318 | 40.79 |
| 09:34 ET | 644 | 40.83 |
| 09:36 ET | 5025 | 40.75 |
| 09:38 ET | 700 | 40.8 |
| 09:39 ET | 200 | 40.83 |
| 09:41 ET | 391 | 40.79 |
| 09:43 ET | 931 | 40.76 |
| 09:45 ET | 100 | 40.78 |
| 09:48 ET | 2289 | 40.81 |
| 09:50 ET | 1575 | 40.79 |
| 09:52 ET | 1100 | 40.77 |
| 09:54 ET | 500 | 40.74 |
| 09:56 ET | 700 | 40.743 |
| 09:57 ET | 200 | 40.79 |
| 09:59 ET | 127 | 40.78 |
| 10:01 ET | 3266 | 40.81 |
| 10:03 ET | 3423 | 40.77 |
| 10:06 ET | 2532 | 40.76 |
| 10:08 ET | 595 | 40.78 |
| 10:10 ET | 400 | 40.78 |
| 10:12 ET | 553 | 40.8 |
| 10:14 ET | 1051 | 40.8101 |
| 10:15 ET | 780 | 40.83 |
| 10:17 ET | 1084 | 40.81 |
| 10:19 ET | 771 | 40.8 |
| 10:21 ET | 700 | 40.75 |
| 10:24 ET | 389 | 40.78 |
| 10:26 ET | 800 | 40.805 |
| 10:28 ET | 1838 | 40.76 |
| 10:30 ET | 1228 | 40.76 |
| 10:32 ET | 1525 | 40.74 |
| 10:33 ET | 700 | 40.73 |
| 10:35 ET | 1987 | 40.67 |
| 10:37 ET | 1291 | 40.66 |
| 10:39 ET | 700 | 40.65 |
| 10:42 ET | 100 | 40.63 |
| 10:44 ET | 200 | 40.61 |
| 10:46 ET | 2207 | 40.61 |
| 10:48 ET | 2282 | 40.61 |
| 10:50 ET | 518 | 40.62 |
| 10:51 ET | 200 | 40.63 |
| 10:53 ET | 300 | 40.63 |
| 10:55 ET | 504 | 40.6 |
| 10:57 ET | 600 | 40.56 |
| 11:00 ET | 800 | 40.56 |
| 11:02 ET | 406 | 40.51 |
| 11:04 ET | 798 | 40.55 |
| 11:06 ET | 268 | 40.5499 |
| 11:08 ET | 600 | 40.54 |
| 11:09 ET | 900 | 40.57 |
| 11:11 ET | 1481 | 40.55 |
| 11:13 ET | 300 | 40.57 |
| 11:15 ET | 900 | 40.595 |
| 11:18 ET | 100 | 40.605 |
| 11:20 ET | 300 | 40.62 |
| 11:22 ET | 508 | 40.64 |
| 11:24 ET | 629 | 40.63 |
| 11:26 ET | 913 | 40.62 |
| 11:27 ET | 1399 | 40.59 |
| 11:29 ET | 400 | 40.6 |
| 11:31 ET | 300 | 40.59 |
| 11:36 ET | 9151 | 40.57 |
| 11:38 ET | 517 | 40.575 |
| 11:40 ET | 100 | 40.575 |
| 11:42 ET | 100 | 40.58 |
| 11:44 ET | 600 | 40.59 |
| 11:45 ET | 200 | 40.59 |
| 11:47 ET | 301 | 40.59 |
| 11:49 ET | 1640 | 40.605 |
| 11:51 ET | 410 | 40.596 |
| 11:56 ET | 300 | 40.61 |
| 11:58 ET | 1478 | 40.58 |
| 12:00 ET | 1107 | 40.58 |
| 12:02 ET | 500 | 40.55 |
| 12:03 ET | 354 | 40.57 |
| 12:05 ET | 500 | 40.56 |
| 12:07 ET | 625 | 40.56 |
| 12:09 ET | 100 | 40.58 |
| 12:12 ET | 854 | 40.55 |
| 12:14 ET | 3054 | 40.5 |
| 12:16 ET | 1044 | 40.49 |
| 12:18 ET | 2935 | 40.42 |
| 12:20 ET | 902 | 40.43 |
| 12:21 ET | 350 | 40.4 |
| 12:25 ET | 853 | 40.41 |
| 12:27 ET | 15628 | 40.47 |
| 12:30 ET | 400 | 40.465 |
| 12:32 ET | 19300 | 40.53 |
| 12:34 ET | 3865 | 40.46 |
| 12:36 ET | 884 | 40.49 |
| 12:38 ET | 1950 | 40.54 |
| 12:39 ET | 3406 | 40.56 |
| 12:41 ET | 2382 | 40.57 |
| 12:43 ET | 348 | 40.58 |
| 12:45 ET | 2360 | 40.56 |
| 12:48 ET | 4150 | 40.57 |
| 12:50 ET | 3907 | 40.61 |
| 12:52 ET | 3539 | 40.605 |
| 12:54 ET | 2933 | 40.61 |
| 12:56 ET | 5455 | 40.6 |
| 12:57 ET | 2636 | 40.57 |
| 12:59 ET | 10060 | 40.58 |
Jul 2, 2024
QIAGEN N.V. to release results for Q2 2024 and hold webcast, from 9:29AM ET on Tuesday Jul 02, 2024 by Dow Jones
9:29AM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 27, 2024
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children, from 4:05PM ET on Thursday Jun 27, 2024 by Dow Jones
4:05PM ET on Thursday Jun 27, 2024 by Dow JonesDJ Qiagen Raised to Outperform From Peer Perform by Wolfe Research, from 6:00AM ET on Thursday Jun 27, 2024 by Dow Jones
6:00AM ET on Thursday Jun 27, 2024 by Dow Jones
Jun 20, 2024
DJ Qiagen on Pace for Largest Percent Decrease Since October 2022 -- Data Talk, from 2:21PM ET on Thursday Jun 20, 2024 by Dow Jones
2:21PM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 18, 2024
DJ Qiagen Is Maintained at Overweight by JP Morgan, from 10:22AM ET on Tuesday Jun 18, 2024 by Dow Jones
10:22AM ET on Tuesday Jun 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Qiagen NV | 9.0B | 26.9x | +12.66% |
Exelixis Inc | 6.4B | 34.0x | -21.77% |
Medpace Holdings Inc | 12.5B | 41.1x | +35.10% |
Exact Sciences Corp | 8.0B | -32.6x | --- |
Neurocrine Biosciences Inc | 13.9B | 38.0x | +62.04% |
Alkermes Plc | 4.1B | 6.9x | --- |
Company Information
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Contact Information
- Headquarters
- Hulsterweg 82VENLO, Netherlands 5912 PL
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Supervisory Board
- Lawrence Rosen
- Chief Executive Officer, Managing Director, Member of the Executive Board
- Thierry Bernard
- Managing Director, Chief Financial Officer, Member of the Executive Board
- Roland Sackers
- Independent Member of the Supervisory Board
- Metin Colpan
- Independent Member of the Supervisory Board
- Toralf Haag
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.0B |
|---|---|
Revenue (TTM) | $1.9B |
Shares Outstanding | 221.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $1.51 |
Book Value | $17.20 |
P/E Ratio | 26.9x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 16.5x |
Operating Margin | 20.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
